Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 44%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc has reported significantly higher revenues and an improved gross margin, which effectively countered increased operating expenses. The company is experiencing rapid growth driven by robust demand for its PCIe Gen 6 products, which contributed over 20% of its revenue in the third quarter of 2025, alongside solid growth from its Aries solutions. Furthermore, Astera's strong revenue guidance of $249.0 million for the upcoming quarter, representing an 8.0% quarter-over-quarter increase and a remarkable 76.5% year-over-year growth, underscores its position as one of the fastest-growing entities in the semiconductor industry, supported by increasing AI server shipments and design wins.

Bears say

Astera Labs Inc's revenue growth is highly reliant on the pace of spending within the data center infrastructure sector, which creates vulnerability to macroeconomic factors that could lead to a slowdown in capital investments. This dependence on fluctuating market conditions presents a risk to the company’s financial performance and stock price stability. Additionally, potential reductions in investment in data centers may adversely affect Astera Labs's overall business prospects and growth trajectory.

ALAB has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 44% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 18 analysts, ALAB has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $187.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $187.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.